The impact of demographic and clinical characteristics on diabetic painful neuropathy

1. BURSON LK, SCHANK CH. Charcot neuroarthropathy of the foot and ankle. Home healthcare now. 2016 Mar; 34(3):135–9.10.1097/NHH.000000000000034826925938Search in Google Scholar

2. FOSSE S, HARTEMANN-HEURTIER A, JACQUEMINET S, HA VAN G, GRIMALDI A, FAGOT-CAMPAGNA A. Incidence and characteristics of lower limb amputations in people with diabetes. Diabet Med. 2009 Apr; 26(4):391–6.10.1111/j.1464-5491.2009.02698.x19388969Search in Google Scholar

3. BECKMAN JA, CREAGER MA. Vascular complications of diabetes. Circulation Research. 2016 May 27; 118(11):1771–85.10.1161/CIRCRESAHA.115.30688427230641Search in Google Scholar

4. POP-BUSUI R, BOULTON AJM, FELDMAN EL, BRIL V, FREEMAN R, MALIK RA, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017 Jan; 40 (1):136–154.10.2337/dc16-2042697740527999003Search in Google Scholar

5. YAGIHASHI S, MIZUKAMI H. Diabetic neuropathy. In: Diabetes and Aging-related Complications. 2017 Jun 15; 8(6):249–269.Search in Google Scholar

6. BOOYA F, BANDARIAN F, LARIJANI B, PAJOUHI M, NOORAEI M, LOTFI J. Potential risk factors for diabetic neuropathy: A case control study. BMC Neurol. 2005 Dec 10; 5:24.10.1186/1471-2377-5-24134357616336693Search in Google Scholar

7. SMITH AG, SINGLETON JR. Obesity and hyperlipidemia are risk factors for early diabetic neuropathy. J Diabetes Complications. 2013 Sep–Oct; 27(5):436–42.10.1016/j.jdiacomp.2013.04.003376640423731827Search in Google Scholar

8. ASLAM A, SINGH J, RAJBHANDARI S. Pathogenesis of painful diabetic neuropathy. Pain Research and Treatment. 2014 (4 i):412041.10.1155/2014/412041402698824891949Search in Google Scholar

9. JAVED S, PETROPOULOS IN, ALAM U, MALIK RA. Treatment of painful diabetic neuropathy. Therapeutic Advances in Chronic Disease. 2015 Jan; 6(1):15–28.10.1177/2040622314552071426961025553239Search in Google Scholar

10. PODWALL D, GOOCH C. Diabetic neuropathy: Clinical features, etiology, and therapy. Current Neurology and Neuroscience Reports. 2004 Jan; 4(1):55–61.10.1007/s11910-004-0013-914683630Search in Google Scholar

11. LOZERON P, NAHUM L, LACROIX C, ROPERT A, GUGLIELMI JM, SAID G. Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients. J Neurol. 2002 May; 249(5):569–75.10.1007/s00415020006612021947Search in Google Scholar

12. DOBRETSOV M, ROMANOVSKY D, STIMERS JR. Early diabetic neuropathy: Triggers and mechanisms. World Journal of Gastroenterology. 2007 Jan 14; 13(2):175–191.10.3748/wjg.v13.i2.175182941117226897Search in Google Scholar

13. WON JC, PARK TS. Recent Advances in Diagnostic Strategies for Diabetic Peripheral Neuropathy. Endocrinol Metab. 2016 Jun; 31(2):230–8.10.3803/EnM.2016.31.2.230492340627246283Search in Google Scholar

14. FELDMAN EL, STEVENS MJ, THOMAS PK, BROWN MB, CANAL N, GREENE DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994 Nov; 17(11):1281–9.10.2337/diacare.17.11.12817821168Search in Google Scholar

15. BOULTON AJM, VINIK AI, AREZZO JC, BRIL V, FELDMAN EL, FREEMAN R, et al. Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care. 2005 Apr; 28(4):956–62.10.2337/diacare.28.4.95615793206Search in Google Scholar

16. PAPANAS N, VINIK AI, ZIEGLER D. Neuropathy in prediabetes: Does the clock start ticking early? Nature Reviews Endocrinology. 2011 Jul 12; 7(11):682–90.10.1038/nrendo.2011.11321750507Search in Google Scholar

17. SINGLETON JR, SMITH AG, BROMBERG MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care. 2001 Aug; 24(8):1448–53.10.2337/diacare.24.8.144811473085Search in Google Scholar

18. KHOSHNOODI MA, TRUELOVE S, BURAKGAZI A, HOKE A, MAMMEN AL, POLYDEFKIS M. Longitudinal assessment of small fiber neuropathy: Evidence of a non-length-dependent distal axonopathy. JAMA Neurol. 2016 Jun 1; 73(6):684–90.10.1001/jamaneurol.2016.005727065313Search in Google Scholar

19. POURHAMIDI K, DAHLIN LB, ENGLUND E, ROLANDSSON O. No difference in small or large nerve fiber function between individuals with normal glucose tolerance and impaired glucose tolerance. Diabetes Care. 2013 Apr;36(4):962–4.10.2337/dc12-1331360948923223347Search in Google Scholar

20. KAUR S, PANDHI P, DUTTA P. Painful diabetic neuropathy: An update. Ann Neurosci. 2011 Oct; 18(4):168–175.10.5214/ans.0972.7531.1118409Search in Google Scholar

21. SNYDER MJ, GIBBS LM, LINDSAY TJ. Treating painful diabetic peripheral neuropathy: An update. Am Fam Physician. Aug 1; 94(3):227–34.Search in Google Scholar

22. MIRANDA-MASSARI JR. B, GONZALEZ MJ. D, JIMENEZ FJ., ALLENDE-VIGO MZ., DUCONGE J. Metabolic correction in the management of diabetic peripheral neuropathy: Improving clinical results beyond symptom control. Curr Clin Pharmacol. 2011 Nov; 6(4):260–73.10.2174/157488411798375967368249822082324Search in Google Scholar

23. GRISOLD A, CALLAGHAN BC, FELDMAN EL. Mediators of diabetic neuropathy. Curr Opin Endocrinol Diabetes Obes. 2017 Apr; 24(2):103–111.10.1097/MED.0000000000000320583154228098594Search in Google Scholar

24. DIREÇÃO GERAL DE SAÚDE. Tratamento farmacológico da dor neuropática no adulto e idoso. Número 043/2011, atualizada a 13/07/2017. 2017Search in Google Scholar